Efficacy and Safety of Intravenous-to-Oral Lascufloxacin Switch Therapy in Community-Onset Pneumonia: A Single-Arm, Open-Label Clinical TrialNaoki Iwanaga, Hiroshi Mukae, Takahiro Takazono et al.|Cureus|2025Cited by 2